Yoshiya Tanaka

1.1k total citations
22 papers, 759 citations indexed

About

Yoshiya Tanaka is a scholar working on Rheumatology, Immunology and Genetics. According to data from OpenAlex, Yoshiya Tanaka has authored 22 papers receiving a total of 759 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 11 papers in Immunology and 4 papers in Genetics. Recurrent topics in Yoshiya Tanaka's work include Psoriasis: Treatment and Pathogenesis (5 papers), Systemic Lupus Erythematosus Research (5 papers) and Spondyloarthritis Studies and Treatments (4 papers). Yoshiya Tanaka is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (5 papers), Systemic Lupus Erythematosus Research (5 papers) and Spondyloarthritis Studies and Treatments (4 papers). Yoshiya Tanaka collaborates with scholars based in Japan, United States and France. Yoshiya Tanaka's co-authors include S. Iwata, Shingo Nakayamada, Sumiya Eto, Satoshi Kubo, Osamu Ishida, Masaharu Takigawa, Isao Morimoto, Kazuhisa Nakano, Maiko Yoshikawa and Kazuyoshi Saito and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Journal of Bone and Mineral Research.

In The Last Decade

Yoshiya Tanaka

20 papers receiving 742 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yoshiya Tanaka Japan	13	475	301	116	97	80	22	759
Yannick Degboé France	20	563 1.2×	342 1.1×	214 1.8×	115 1.2×	152 1.9×	70	1.1k
A Trabandt Germany	17	589 1.2×	329 1.1×	79 0.7×	83 0.9×	163 2.0×	31	1.2k
Kotaro Otomo Japan	17	752 1.6×	429 1.4×	254 2.2×	31 0.3×	86 1.1×	38	1.2k
Jianping Guo China	18	322 0.7×	357 1.2×	91 0.8×	186 1.9×	120 1.5×	50	964
Hisaaki Miyahara Japan	16	399 0.8×	293 1.0×	124 1.1×	61 0.6×	138 1.7×	55	910
Hironari Hanaoka Japan	14	345 0.7×	121 0.4×	30 0.3×	42 0.4×	89 1.1×	74	613
Michishi Tsukano Japan	17	504 1.1×	279 0.9×	202 1.7×	100 1.0×	125 1.6×	40	1.1k
Koshiro Sonomoto Japan	16	408 0.9×	199 0.7×	77 0.7×	274 2.8×	127 1.6×	61	895
Daiki Nakagomi Japan	16	470 1.0×	181 0.6×	105 0.9×	104 1.1×	46 0.6×	61	906
Ayako Nishino Japan	14	325 0.7×	229 0.8×	80 0.7×	41 0.4×	62 0.8×	48	647

Countries citing papers authored by Yoshiya Tanaka

Since Specialization

Citations

This map shows the geographic impact of Yoshiya Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiya Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiya Tanaka more than expected).

Fields of papers citing papers by Yoshiya Tanaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiya Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiya Tanaka. The network helps show where Yoshiya Tanaka may publish in the future.

Co-authorship network of co-authors of Yoshiya Tanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiya Tanaka. A scholar is included among the top collaborators of Yoshiya Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiya Tanaka. Yoshiya Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

He, Yi, Jannie Marie Bülow Sand, Satoshi Kubo, et al.. (2025). Accelerated Type VII collagen turnover in systemic sclerosis patients, reflected by serological neo-epitope fragment biomarkers. Arthritis Research & Therapy. 27(1). 58–58. 1 indexed citations

Nakayamada, Shingo, Ippei Miyagawa, Yusuke Miyazaki, et al.. (2025). Association of exercise-induced pulmonary hypertension with nailfold capillary density in systemic sclerosis: a single-center retrospective observational study. Arthritis Research & Therapy. 27(1). 169–169.

McInnes, Iain B., Philip J. Mease, Yoshiya Tanaka, et al.. (2023). POS1537 BIMEKIZUMAB EFFICACY AND SAFETY IN BIOLOGIC DMARD-NAÏVE PATIENTS WITH PSORIATIC ARTHRITIS WAS CONSISTENT WITH OR WITHOUT METHOTREXATE: 52-WEEK RESULTS FROM THE PHASE 3 ACTIVE‑REFERENCE STUDY BE OPTIMAL. Annals of the Rheumatic Diseases. 82. 1133–1134. 3 indexed citations

Miyagawa, Ippei, Shingo Nakayamada, Masanobu Ueno, et al.. (2022). Precision medicine based on the phenotypic differences in peripheral T helper cells in patients with psoriatic arthritis: One year follow-up outcomes. Frontiers in Medicine. 9. 934937–934937. 5 indexed citations

Merola, Joseph F., Robert Landewé, Iain B. McInnes, et al.. (2022). Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE). The Lancet. 401(10370). 38–48. 104 indexed citations

Miyagawa, Ippei, Kazuhisa Nakano, Shingo Nakayamada, et al.. (2020). The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus. International Journal of Rheumatic Diseases. 23(4). 549–558. 10 indexed citations

Iwata, S., Mingzeng Zhang, Hao He, et al.. (2020). Enhanced Fatty Acid Synthesis Leads to Subset Imbalance and IFN-γ Overproduction in T Helper 1 Cells. Frontiers in Immunology. 11. 593103–593103. 24 indexed citations

Nakayamada, Shingo, Yusuke Miyazaki, Ippei Miyagawa, et al.. (2019). SAT0026 IMPACT OF TOCILIZUMAB ON IMMUNE PHENOTYPES IN PATIENTS WITH LARGE VESSEL VASCULITIS. Annals of the Rheumatic Diseases. 78. 1077–1078. 1 indexed citations

Miyagawa, Ippei, Kazuhisa Nakano, Shingo Nakayamada, et al.. (2018). Effectiveness and safety of hydroxychloroquine therapy with or without corticosteroid in patients with systemic lupus erythematosus. International Journal of Rheumatic Diseases. 22(3). 434–442. 15 indexed citations

10.

Sakata, Kei, et al.. (2018). Hydroxychloroquine efficiently suppresses inflammatory responses of human class-switched memory B cells via Toll-like receptor 9 inhibition. Clinical Immunology. 195. 1–7. 63 indexed citations

11.

Miyazaki, Yusuke, Shingo Nakayamada, Satoshi Kubo, et al.. (2018). Th22 Cells Promote Osteoclast Differentiation via Production of IL-22 in Rheumatoid Arthritis. Frontiers in Immunology. 9. 2901–2901. 51 indexed citations

12.

Ohkubo, Naoaki, Kazuhisa Nakano, Ippei Miyagawa, et al.. (2018). Successful treatment with etanercept in a case of seronegative rheumatoid arthritis with corticosteroid/methotrexate-resistant pemphigus erythematosus. Modern Rheumatology Case Reports. 2(2). 137–142.

13.

Miyagawa, Ippei, Shingo Nakayamada, Kazuhisa Nakano, et al.. (2018). Precision medicine using different biological DMARDs based on characteristic phenotypes of peripheral T helper cells in psoriatic arthritis. Lara D. Veeken. 58(2). 336–344. 78 indexed citations

14.

Iwata, S., Shingo Nakayamada, Hiroaki Niiro, et al.. (2015). Amplification of IL-21 signalling pathway through Bruton’s tyrosine kinase in human B cell activation. Lara D. Veeken. 54(8). 1488–1497. 36 indexed citations

15.

Iwata, S., Shingo Nakayamada, Shunsuke Fukuyo, et al.. (2014). Activation of Syk in Peripheral Blood B Cells in Patients With Rheumatoid Arthritis: A Potential Target for Abatacept Therapy. Arthritis & Rheumatology. 67(1). 63–73. 54 indexed citations

16.

Suzuki, Katsunori, Kazuyoshi Saito, Shizuyo Tsujimura, et al.. (2010). Tacrolimus, a Calcineurin Inhibitor, Overcomes Treatment Unresponsiveness Mediated by P-glycoprotein on Lymphocytes in Refractory Rheumatoid Arthritis. The Journal of Rheumatology. 37(3). 512–520. 50 indexed citations

17.

Takeuchi, Tsutomu, Hisashi Yamanaka, Eisuke Inoue, et al.. (2008). Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year outcome of joint destruction (RECONFIRM-2J). Modern Rheumatology. 18(5). 447–454. 41 indexed citations

18.

Yamaoka, Kunihiro, Kazuyoshi Saito, Kentaro Hanami, et al.. (2007). A case of life-threatening refractory polychondritis successfully treated with combined intensive immunosuppressive therapy with methotrexate. Modern Rheumatology. 17(2). 144–147. 12 indexed citations

19.

Komiya, Ichiro, Takeo Nishimori, Yoshiharu Ito, et al.. (2000). An Elevation of Serum Immunoglobulin E Provides a New Aspect of Hyperthyroid Graves’ Disease. The Journal of Clinical Endocrinology & Metabolism. 85(8). 2775–2778. 41 indexed citations

20.

Ishida, Osamu, Yoshiya Tanaka, Isao Morimoto, Masaharu Takigawa, & Sumiya Eto. (1997). Chondrocytes Are Regulated by Cellular Adhesion Through CD44 and Hyaluronic Acid Pathway. Journal of Bone and Mineral Research. 12(10). 1657–1663. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact